Initiation of GLP-1 receptor agonist therapy was associated with a lower risk of several substance use disorders (SUDs) in adults with type 2 diabetes. The study emulated a target study using data on veterans. It concerned patients without a history of SUD. GLP-1 drugs can prevent and treat multiple addictions. Research indicates a positive effect on addiction to alcohol and opiates, although they are not officially approved for this purpose.